Urologix Company Profile (OTCMKTS:ULGX)

About Urologix

Urologix logo21st North Inc., formerly Urologix Inc., was engaged in developing, manufacturing, marketing and distributing medical products. The Company offered its products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The Company has no operations. The Company intends to dissolve.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: ULGX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $
  • 200 Day Moving Average: $
  • Trailing P/E Ratio:
  • Foreward P/E Ratio: -0.01
  • P/E Growth:
  • Market Cap: $
  • Outstanding Shares: 21,282,000
  • Beta: 2.72
Additional Links:
Companies Related to Urologix:

Analyst Ratings

Consensus Ratings for Urologix (OTCMKTS:ULGX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Urologix (OTCMKTS:ULGX)
No equities research coverage for this company has been tracked by MarketBeat.com


Earnings History for Urologix (OTCMKTS:ULGX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/5/2015Q215($0.02)$3.80 million$3.10 millionViewListenView Earnings Details
8/19/2014Q4 14($0.17)$3.29 millionViewN/AView Earnings Details
2/4/2014Q4($0.05)ViewListenView Earnings Details
11/14/2012Q113($0.06)($0.05)$4.48 million$4.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Urologix (OTCMKTS:ULGX)
Current Year EPS Consensus Estimate: $-0.2100 EPS
Next Year EPS Consensus Estimate: $-0.2300 EPS


Dividend History for Urologix (OTCMKTS:ULGX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Urologix (OTCMKTS:ULGX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/26/2013Gregory FluetCEOBuy17,500$0.31$5,425.00View SEC Filing  
7/12/2013Mitchell DannDirectorBuy20,000$0.30$6,000.00View SEC Filing  
7/10/2013Gregory FluetCEOBuy25,000$0.24$6,000.00View SEC Filing  
7/9/2013Lisa A AckermannEVPBuy18,500$0.24$4,440.00View SEC Filing  
7/8/2013Gregory FluetCEOBuy66,400$0.19$12,616.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Urologix (OTCMKTS:ULGX)
finance.yahoo.com logo21st North Inc. (formerly known as Urologix, Inc.) Announces Expected Timeline for Administrative Dissolution of the Company (OTCMKTS:ULGX)
finance.yahoo.com - April 25 at 3:05 PM
finance.yahoo.com logoUrologix Announces Sale of Operating Assets to Private Company Buyer (OTCMKTS:ULGX)
finance.yahoo.com - February 2 at 4:05 PM
finance.yahoo.com logoUROLOGIX INC Financials (OTCMKTS:ULGX)
finance.yahoo.com - December 8 at 1:11 PM
finance.yahoo.com logoEdited Transcript of ULGX earnings conference call or presentation 12-May-15 9:00pm GMT (OTCMKTS:ULGX)
finance.yahoo.com - July 16 at 7:03 PM
biz.yahoo.com logoUROLOGIX INC Files SEC form 8-K, Other Events (OTCMKTS:ULGX)
biz.yahoo.com - July 10 at 4:01 PM
noodls.com logoUrologix Announces SEC Deregistration (OTCMKTS:ULGX)
www.noodls.com - July 9 at 4:21 PM
noodls.com logoCosts for In-Office BPH Therapies Presented at the AUA 2015 Annual Meeting in New Orleans (OTCMKTS:ULGX)
www.noodls.com - May 21 at 4:33 PM
biz.yahoo.com logoUROLOGIX INC Files SEC form 10-Q, Quarterly Report (OTCMKTS:ULGX)
biz.yahoo.com - May 14 at 4:16 PM
biz.yahoo.com logoUROLOGIX INC Files SEC form 8-K, Results of Operations and Financial Condition (OTCMKTS:ULGX)
biz.yahoo.com - May 13 at 7:09 AM
noodls.com logoUrologix Products Featured in Cost-Effectiveness Research to be Presented at Upcoming Industry Meeting in New Orleans (OTCMKTS:ULGX)
www.noodls.com - May 12 at 4:46 PM
noodls.com logoUrologix Reports Third Quarter Fiscal Year 2015 Results (OTCMKTS:ULGX)
www.noodls.com - May 12 at 4:46 PM
noodls.com logoUrologix to Host Its Fiscal Year 2015 Third Quarter Conference Call (OTCMKTS:ULGX)
www.noodls.com - May 5 at 4:33 PM
biz.yahoo.com logoUROLOGIX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (OTCMKTS:ULGX)
biz.yahoo.com - March 23 at 2:02 PM
noodls.com logoUrologix Announces Hiring of Chief Financial Officer (OTCMKTS:ULGX)
www.noodls.com - March 23 at 9:11 AM
biz.yahoo.com logoUROLOGIX INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events (OTCMKTS:ULGX)
biz.yahoo.com - January 12 at 8:10 AM


Urologix (OTCMKTS:ULGX) Chart for Monday, August, 29, 2016

Last Updated on 8/29/2016 by MarketBeat.com Staff